iStopMM study changes the definition of multiple myeloma precursor condition

February 5, 2023

Recently an interview appeared in Nordic Life Science with Thorir Long author of Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study, that was published in Blood Cancer Journal recently.

Share this post

More to explore

New study from iStopMM: MGUS is not associated with increased risk of COVID-19 or severe COVID-19

December 7, 2021

Myeloma patients have an increased risk of severe COVID-19. MGUS, the precursor of myeloma, has previously been associated with an increased risk of infections, the

High prevalence of smoldering myeloma observed in nationwide screening study

December 16, 2021

In an article in CancerTherapyAdvisor.com the iStopMM study and it‘s results are covered. Results from the study were presented at the 2021 American Society of

iStopMM presenting 6 abstracts at ASH 2021

December 3, 2021

International Myeloma Foundation press release: iStopMM charts the way forward in Myeloma research and treatment. This year, iStopMM presents four oral abstracts and two posters